LXRX logo

Lexicon Pharmaceuticals, Inc. (LXRX) Revenue

Annual Revenue:

$31.08M+$29.88M(+2481.48%)
December 31, 2024

Summary

  • As of today, LXRX annual revenue is $31.08 million, with the most recent change of +$29.88 million (+2481.48%) on December 31, 2024.
  • During the last 3 years, LXRX annual revenue has risen by +$30.78 million (+10329.87%).
  • LXRX annual revenue is now -90.35% below its all-time high of $322.07 million, reached on December 31, 2019.

Performance

LXRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

Quarterly Revenue:

$14.18M-$14.68M(-50.87%)
September 30, 2025

Summary

  • As of today, LXRX quarterly revenue is $14.18 million, with the most recent change of -$14.68 million (-50.87%) on September 30, 2025.
  • Over the past year, LXRX quarterly revenue has increased by +$12.43 million (+710.40%).
  • LXRX quarterly revenue is now -95.18% below its all-time high of $294.45 million, reached on September 30, 2019.

Performance

LXRX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

TTM Revenue:

$70.86M+$12.43M(+21.28%)
September 30, 2025

Summary

  • As of today, LXRX TTM revenue is $70.86 million, with the most recent change of +$12.43 million (+21.28%) on September 30, 2025.
  • Over the past year, LXRX TTM revenue has increased by +$65.64 million (+1255.21%).
  • LXRX TTM revenue is now -78.55% below its all-time high of $330.42 million, reached on September 30, 2019.

Performance

LXRX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLXRXincome statement metrics

LXRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+2481.5%+710.4%+1255.2%
3Y3 Years+10000.0%+10000.0%+10000.0%
5Y5 Years-90.3%+113.8%+117.9%

LXRX Revenue Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high>+9999.0%-50.9%>+9999.0%at high>+9999.0%
5Y5-Year-90.3%>+9999.0%-50.9%>+9999.0%at high>+9999.0%
All-TimeAll-Time-90.3%>+9999.0%-95.2%>+9999.0%-78.5%>+9999.0%

LXRX Revenue History

DateAnnualQuarterlyTTM
Sep 2025
-
$14.18M(-50.9%)
$70.86M(+21.3%)
Jun 2025
-
$28.87M(+2187.3%)
$58.43M(+87.2%)
Mar 2025
-
$1.26M(-95.2%)
$31.21M(+0.4%)
Dec 2024
$31.08M(+2481.5%)
$26.55M(+1417.4%)
$31.08M(+494.4%)
Sep 2024
-
$1.75M(+6.3%)
$5.23M(+43.6%)
Jun 2024
-
$1.65M(+45.8%)
$3.64M(+57.6%)
Mar 2024
-
$1.13M(+61.0%)
$2.31M(+91.8%)
Dec 2023
$1.20M(+766.2%)
$702.00K(+333.3%)
$1.21M(+126.9%)
Sep 2023
-
$162.00K(-48.9%)
$531.00K(+30.1%)
Jun 2023
-
$317.00K(+1220.8%)
$408.00K(+223.8%)
Mar 2023
-
$24.00K(-14.3%)
$126.00K(-9.4%)
Dec 2022
$139.00K(-53.4%)
$28.00K(-28.2%)
$139.00K(+11.2%)
Sep 2022
-
$39.00K(+11.4%)
$125.00K(+14.7%)
Jun 2022
-
$35.00K(-5.4%)
$109.00K(-64.6%)
Mar 2022
-
$37.00K(+164.3%)
$308.00K(+3.4%)
Dec 2021
$298.00K(-98.8%)
$14.00K(-39.1%)
$298.00K(-38.3%)
Sep 2021
-
$23.00K(-90.2%)
$483.00K(-93.2%)
Jun 2021
-
$234.00K(+766.7%)
$7.09M(-55.7%)
Mar 2021
-
$27.00K(-86.4%)
$16.02M(-33.2%)
Dec 2020
$24.00M(-92.5%)
$199.00K(-97.0%)
$24.00M(-26.2%)
Sep 2020
-
$6.63M(-27.6%)
$32.52M(-89.8%)
Jun 2020
-
$9.16M(+14.6%)
$320.34M(-0.2%)
Mar 2020
-
$8.00M(-8.3%)
$320.86M(-0.4%)
Dec 2019
$322.07M(+409.5%)
$8.73M(-97.0%)
$322.07M(-2.5%)
Sep 2019
-
$294.45M(+2941.2%)
$330.42M(+669.6%)
Jun 2019
-
$9.68M(+5.1%)
$42.94M(-8.7%)
Mar 2019
-
$9.22M(-46.0%)
$47.05M(-25.6%)
Dec 2018
$63.21M(-31.1%)
$17.07M(+145.1%)
$63.21M(-20.2%)
Sep 2018
-
$6.97M(-49.5%)
$79.19M(-20.1%)
Jun 2018
-
$13.80M(-45.6%)
$99.16M(+1.8%)
Mar 2018
-
$25.37M(-23.2%)
$97.42M(+7.8%)
Dec 2017
$91.69M(+10.0%)
$33.05M(+22.7%)
$90.33M(+12.5%)
Sep 2017
-
$26.94M(+123.5%)
$80.33M(-1.0%)
Jun 2017
-
$12.05M(-34.1%)
$81.10M(-9.0%)
Mar 2017
-
$18.29M(-20.6%)
$89.14M(+7.0%)
Dec 2016
$83.34M(-35.9%)
$23.04M(-16.9%)
$83.34M(+38.2%)
Sep 2016
-
$27.72M(+38.0%)
$60.30M(+81.9%)
Jun 2016
-
$20.09M(+60.8%)
$33.15M(+146.7%)
Mar 2016
-
$12.49M(+2107.4%)
$13.44M(-44.5%)
Dec 2015
$130.01M(+468.9%)
-
-
Sep 2015
-
$566.00K(+50.5%)
$24.22M(+0.6%)
Jun 2015
-
$376.00K(-79.0%)
$24.07M(-1.2%)
Mar 2015
-
$1.79M(-91.7%)
$24.37M(+6.6%)
Dec 2014
$22.85M(+928.5%)
$21.48M(+5027.0%)
$22.85M(+721.5%)
Sep 2014
-
$419.00K(-38.0%)
$2.78M(+7.0%)
Jun 2014
-
$676.00K(+144.0%)
$2.60M(+21.6%)
Mar 2014
-
$277.00K(-80.4%)
$2.14M(-3.7%)
Dec 2013
$2.22M(+104.0%)
$1.41M(+492.4%)
$2.22M(+115.7%)
Sep 2013
-
$238.00K(+11.2%)
$1.03M(-11.5%)
Jun 2013
-
$214.00K(-40.6%)
$1.16M(+1.3%)
Mar 2013
-
$360.00K(+65.1%)
$1.15M(+5.5%)
Dec 2012
$1.09M
$218.00K(-41.4%)
$1.09M(-10.3%)
Sep 2012
-
$372.00K(+86.9%)
$1.21M(+1.4%)
DateAnnualQuarterlyTTM
Jun 2012
-
$199.00K(-33.7%)
$1.20M(-22.9%)
Mar 2012
-
$300.00K(-12.5%)
$1.55M(-16.0%)
Dec 2011
$1.85M(-62.3%)
$343.00K(-3.4%)
$1.85M(-33.0%)
Sep 2011
-
$355.00K(-36.0%)
$2.76M(-13.4%)
Jun 2011
-
$555.00K(-6.9%)
$3.19M(-17.6%)
Mar 2011
-
$596.00K(-52.4%)
$3.86M(-21.3%)
Dec 2010
$4.91M(-54.1%)
$1.25M(+60.4%)
$4.91M(-3.1%)
Sep 2010
-
$781.00K(-36.7%)
$5.07M(-21.0%)
Jun 2010
-
$1.23M(-24.9%)
$6.42M(-21.5%)
Mar 2010
-
$1.64M(+16.2%)
$8.17M(-23.6%)
Dec 2009
$10.70M(-66.9%)
$1.41M(-33.7%)
$10.70M(-31.6%)
Sep 2009
-
$2.13M(-28.7%)
$15.64M(-25.6%)
Jun 2009
-
$2.99M(-28.3%)
$21.02M(-23.8%)
Mar 2009
-
$4.17M(-34.4%)
$27.60M(-14.6%)
Dec 2008
$32.32M(-35.5%)
$6.35M(-15.5%)
$32.32M(-18.7%)
Sep 2008
-
$7.51M(-21.5%)
$39.78M(-6.3%)
Jun 2008
-
$9.57M(+7.6%)
$42.43M(-6.8%)
Mar 2008
-
$8.89M(-35.6%)
$45.52M(-9.2%)
Dec 2007
$50.12M(-31.2%)
$13.81M(+35.8%)
$50.12M(-4.3%)
Sep 2007
-
$10.17M(-19.6%)
$52.38M(-15.3%)
Jun 2007
-
$12.65M(-6.3%)
$61.82M(-5.4%)
Mar 2007
-
$13.49M(-16.0%)
$65.34M(-10.2%)
Dec 2006
$72.80M(-3.8%)
$16.07M(-18.1%)
$72.80M(-19.7%)
Sep 2006
-
$19.61M(+21.3%)
$90.63M(+6.6%)
Jun 2006
-
$16.16M(-22.9%)
$84.98M(+2.7%)
Mar 2006
-
$20.95M(-38.2%)
$82.71M(+9.3%)
Dec 2005
$75.68M(+22.6%)
$33.89M(+142.7%)
$75.68M(+11.6%)
Sep 2005
-
$13.96M(+0.5%)
$67.80M(+1.3%)
Jun 2005
-
$13.90M(-0.2%)
$66.94M(+4.9%)
Mar 2005
-
$13.93M(-46.5%)
$63.82M(+3.4%)
Dec 2004
$61.74M(+44.1%)
$26.01M(+98.4%)
$61.74M(+24.9%)
Sep 2004
-
$13.11M(+21.6%)
$49.43M(+2.1%)
Jun 2004
-
$10.78M(-9.0%)
$48.43M(+4.0%)
Mar 2004
-
$11.84M(-13.6%)
$46.57M(+8.7%)
Dec 2003
$42.84M(+21.7%)
$13.70M(+13.1%)
$42.84M(+9.1%)
Sep 2003
-
$12.11M(+35.8%)
$39.26M(+11.7%)
Jun 2003
-
$8.92M(+10.1%)
$35.16M(-1.4%)
Mar 2003
-
$8.11M(-19.9%)
$35.65M(+1.3%)
Dec 2002
$35.20M(+15.1%)
$10.12M(+26.3%)
$35.20M(-0.4%)
Sep 2002
-
$8.01M(-14.9%)
$35.35M(-13.4%)
Jun 2002
-
$9.41M(+22.9%)
$40.83M(+16.9%)
Mar 2002
-
$7.66M(-25.5%)
$34.92M(+14.2%)
Dec 2001
$30.58M(+111.5%)
$10.27M(-23.9%)
$30.58M(+31.6%)
Sep 2001
-
$13.49M(+285.3%)
$23.23M(+51.3%)
Jun 2001
-
$3.50M(+5.8%)
$15.35M(+6.4%)
Mar 2001
-
$3.31M(+13.3%)
$14.43M(-0.2%)
Dec 2000
$14.46M(+205.2%)
$2.92M(-47.9%)
$14.46M(+25.3%)
Sep 2000
-
$5.61M(+117.4%)
$11.54M(+94.8%)
Jun 2000
-
$2.58M(-22.7%)
$5.92M(+77.3%)
Mar 2000
-
$3.34M
$3.34M
Dec 1999
$4.74M(+111.3%)
-
-
Dec 1998
$2.24M(+131.7%)
-
-
Dec 1997
$967.70K(+216.2%)
-
-
Dec 1996
$306.00K
-
-

FAQ

  • What is Lexicon Pharmaceuticals, Inc. annual revenue?
  • What is the all-time high annual revenue for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. annual revenue year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. quarterly revenue?
  • What is the all-time high quarterly revenue for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. quarterly revenue year-on-year change?
  • What is Lexicon Pharmaceuticals, Inc. TTM revenue?
  • What is the all-time high TTM revenue for Lexicon Pharmaceuticals, Inc.?
  • What is Lexicon Pharmaceuticals, Inc. TTM revenue year-on-year change?

What is Lexicon Pharmaceuticals, Inc. annual revenue?

The current annual revenue of LXRX is $31.08M

What is the all-time high annual revenue for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high annual revenue is $322.07M

What is Lexicon Pharmaceuticals, Inc. annual revenue year-on-year change?

Over the past year, LXRX annual revenue has changed by +$29.88M (+2481.48%)

What is Lexicon Pharmaceuticals, Inc. quarterly revenue?

The current quarterly revenue of LXRX is $14.18M

What is the all-time high quarterly revenue for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high quarterly revenue is $294.45M

What is Lexicon Pharmaceuticals, Inc. quarterly revenue year-on-year change?

Over the past year, LXRX quarterly revenue has changed by +$12.43M (+710.40%)

What is Lexicon Pharmaceuticals, Inc. TTM revenue?

The current TTM revenue of LXRX is $70.86M

What is the all-time high TTM revenue for Lexicon Pharmaceuticals, Inc.?

Lexicon Pharmaceuticals, Inc. all-time high TTM revenue is $330.42M

What is Lexicon Pharmaceuticals, Inc. TTM revenue year-on-year change?

Over the past year, LXRX TTM revenue has changed by +$65.64M (+1255.21%)
On this page